AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors

LOUISVILLE, CO — (Marketwired) — 03/22/17 — AntriaBio, Inc. (“AntriaBio or the “Company”) (OTCQB: ANTB), a biopharmaceutical growth company specializing in the development of innovative drug therap…Read More »

AntriaBio Announces Offer to Amend Warrants to Purchase Shares of Common Stock

LOUISVILLE, CO — (Marketwired) — 12/15/16 — AntriaBio, Inc. (“AntriaBio” or the “Company”) (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, ann…Read More »

AntriaBio Announces Formation of Subsidiary and Plan to Raise Capital in South Korea

Company Targeting Substantial Capital Raise in South Korea in Q4 2016 LOUISVILLE, CO — (Marketwired) — 09/22/16 — AntriaBio, Inc. (“AntriaBio” or the “Company”) (OTCQB: ANTB), a biopharmaceutical c…Read More »

AntriaBio Announces $12 Million Private Placement

LOUISVILLE, CO — (Marketwired) — 06/29/16 — AntriaBio, Inc. (“AntriaBio” or the “Company”) (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, ann…Read More »

AntriaBio Announces Preclinical Proof of Concept for Once-Weekly Basal Insulin AB101 in Diabetic Miniature Swine

LOUISVILLE, CO — (Marketwired) — 06/22/16 — AntriaBio, Inc. (“AntriaBio” or the “Company”) (OTCQB: ANTB), a biopharmaceutical corporation developing novel extended release therapies, released precl…Read More »

Forward Looking Statements

This release, like many written and oral communications presented by AntriaBio, Inc., and our authorized officers, may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of said safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of the Company, are generally identified by use of words "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "seek," "strive," "try," or future or conditional verbs such as "could," "may," "should," "will," "would," or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable law or regulation, AntriaBio undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

This Blog is official and sanctioned by AntriaBio, Inc. | See Disclaimer and Terms of Use

Get AntriaBio, Inc. Blog Post Alerts